首页> Bioengineering (Basel, Switzerland)> Predictive Model of Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia on Event-Free Survival: Data Analysis Based on Trial AAML0531.

Predictive Model of Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia on Event-Free Survival: Data Analysis Based on Trial AAML0531.

导出 LinkOut

翻译打印收藏纠错

第一作者： Kun-Yin,Qiu

第一单位： Department of Hematology/Oncology, Children's Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.;Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.

作者： Kun-Yin,Qiu ^[1] ; Xiong-Yu,Liao ^[1] ; Jian-Pei,Fang ^[1] ; Dun-Hua,Zhou ^[1]

作者单位： Department of Hematology/Oncology, Children's Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.;Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China. ^[1]

关键词 acute myeloid leukemia children gemtuzumab ozogamicin predictive model trial AAML0531

DOI 10.3390/bioengineering12030297

PMID 40150760

发布时间 2025-03-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Bioengineering (Basel, Switzerland)

2025年12卷3期

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Bioengineering (Basel, Switzerland)

2025年12卷3期

检索历史清除

Predictive Model of Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia on Event-Free Survival: Data Analysis Based on Trial AAML0531.

Bioengineering (Basel, Switzerland)

相似文献

同项目论文

Bioengineering (Basel, Switzerland)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Predictive Model of Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia on Event-Free Survival: Data Analysis Based on Trial AAML0531.

Bioengineering (Basel, Switzerland)

相似文献

同项目论文

Bioengineering (Basel, Switzerland)

相关期刊

检索历史清除